Explore our materials

Asian Conference on Hepatitis and AIDS (ACHA) 2016

The study of anti HIV/AIDS in Nanjing | Dr. Wei Zhao

European Meeting on HIV & Hepatitis 2016

Session 7 Discussion

Jens Verheyen

MD, PhD

European Meeting on HIV & Hepatitis 2016

Improving PI drug resistance scores | Jens Verheyen, MD, PhD

Linos Vandekerckhove

MD, PhD

European Meeting on HIV & Hepatitis 2016

PI remain important options for first line | Linos Vandekerckhove, MD, PhD

European Meeting on HIV & Hepatitis 2016

Session 5 Discussion

Charles Boucher

MD, PhD

European Meeting on HIV & Hepatitis 2016

Maintenance Therapy - What is the scientific/ virological rational | Charles Boucher, MD, PhD

European Meeting on HIV & Hepatitis 2016

HIV attachment Inhibitors - Educational lecture in collaboration with ESAR | Thomas Klimkait, MD

European Meeting on HIV & Hepatitis 2016

Session 4 Discussion

European Meeting on HIV & Hepatitis 2016

Community perspective | Rebekah Webb

Pep Coll

MD, MS

European Meeting on HIV & Hepatitis 2016

Roadblocks to implementation | Pep Coll, MD

CFP

Carlo Federico Perno

MD, PhD

European Meeting on HIV & Hepatitis 2016

HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhD

Ravindra Gupta

MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSci